Home › Funds › Euclidean Capital LLC › PMVP
Euclidean Capital LLC position in PMVP
PMV PHARMACEUTICALS INC · Health Care
Euclidean Capital LLC reported holding 2,627,643 shares of PMVP (PMV PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 1.36% of its reported portfolio and ranking #6 among its reported holdings. Euclidean Capital LLC has disclosed PMVP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Euclidean Capital LLC's PMVP position evolved
Euclidean Capital LLC first disclosed a stake in PMVP in Q3 2023 at 2,627,643 shares (US$16.1M). Across 13 filings, Euclidean Capital LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,627,643 shares valued at US$4.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.63M | $16.13M | New |
| Q4 2023 | 2.63M | $8.15M | Hold |
| Q1 2024 | 2.63M | $4.47M | Hold |
| Q2 2024 | 2.63M | $4.26M | Hold |
| Q3 2024 | 2.63M | $3.92M | Hold |
| Q4 2024 | 2.63M | $3.97M | Hold |
| Q1 2025 | 2.63M | $2.86M | Hold |
| Q2 2025 | 2.63M | $2.79M | Hold |
| Q3 2025 | 2.63M | $3.68M | Hold |
| Q4 2025 | 2.63M | $3.28M | Hold |
| Q1 2026 | 2.63M | $3.26M | Hold |
| Q2 2026 | 2.63M | $3.52M | Hold |
| Q3 2026 | 2.63M | $4.39M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PMVP and 13F data
PMVP (PMV PHARMACEUTICALS INC) is a Health Care company. 24 other funds we track also report a position in PMVP — the largest reported positions include BML Capital Management, LLC (US$12.2M), TANG CAPITAL MANAGEMENT LLC (US$12.2M), Samsara BioCapital, LLC (US$12.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PMVP
- BML Capital Management, LLC 7.33M sh · $12.24M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 7.29M sh · $12.17M · Q3 2026
- Samsara BioCapital, LLC 7.24M sh · $12.09M · Q3 2026
- Sio Capital Management, LLC 3.63M sh · $6.07M · Q3 2026
- Boxer Capital Management, LLC 2.05M sh · $3.42M · Q3 2026
- Aldebaran Capital, LLC 489.54K sh · $817.53K · Q3 2026
More on Euclidean Capital LLC
FAQ
How long has Euclidean Capital LLC held PMVP?
Euclidean Capital LLC has disclosed PMVP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Euclidean Capital LLC's current position in PMVP?
As of Q3 2026, Euclidean Capital LLC holds 2.63M shares of PMVP (PMV PHARMACEUTICALS INC), valued at $4.39M, representing 1.36% of its reported portfolio and ranking #6.
Has Euclidean Capital LLC been buying or selling PMVP?
In the latest 13F filing (Q3 2026), Euclidean Capital LLC held unchanged its position in PMVP.
Which other funds hold PMVP?
Other major institutional holders of PMVP include BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Samsara BioCapital, LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.